Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Cohen

Showing results (391-400 of 403) with videos related to

Pageof 41
Sort By:
Circulation. Heart Failure|January 11, 2011
A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trialDavid A Baran, Mark J Zucker, Luis H Arroyo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 21, 2019
Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54Mikael Dellborg, Marc P Bonaca, Robert F Storey, et al.
The New England Journal of Medicine|March 17, 2015
Long-term use of ticagrelor in patients with prior myocardial infarctionMarc P Bonaca, Deepak L Bhatt, Marc Cohen, et al.
Journal of the American Heart Association|December 21, 2018
Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54Marc P Bonaca, Stephen D Wiviott, David A Morrow, et al.
Thrombosis and Haemostasis|April 6, 2021
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID TrialMark Goldin, Dimitrios Giannis, Wassim Diab, et al.
Acta Neuropathologica|May 17, 2024
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumorsAndrew L Lin, Vasilisa A Rudneva, Allison L Richards, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2025
Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study)Linda Chen, Marc Cohen, Vaios Hatzglou, et al.
European Journal of Trauma & Dissociation = Revue Europeenne Du Trauma Et De La Dissociation|April 15, 2024
Psychological impact of the outbreak of COVID-19 on Holocaust survivors in FranceSamuel Sarfati, Andrée Katz, Marc Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2025
Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163Nabil F Saba, Yael Flamand, Derrick T Lin, et al.
Circulation|November 13, 2020
Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic DiseaseNicholas A Marston, Parth N Patel, Frederick K Kamanu, et al.
Pageof 41

Showing results (391-400 of 403) with videos related to

Sort By:
Pageof 41
Circulation. Heart Failure|January 11, 2011
A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trialDavid A Baran, Mark J Zucker, Luis H Arroyo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 21, 2019
Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54Mikael Dellborg, Marc P Bonaca, Robert F Storey, et al.
The New England Journal of Medicine|March 17, 2015
Long-term use of ticagrelor in patients with prior myocardial infarctionMarc P Bonaca, Deepak L Bhatt, Marc Cohen, et al.
Journal of the American Heart Association|December 21, 2018
Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54Marc P Bonaca, Stephen D Wiviott, David A Morrow, et al.
Thrombosis and Haemostasis|April 6, 2021
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID TrialMark Goldin, Dimitrios Giannis, Wassim Diab, et al.
Acta Neuropathologica|May 17, 2024
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumorsAndrew L Lin, Vasilisa A Rudneva, Allison L Richards, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2025
Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study)Linda Chen, Marc Cohen, Vaios Hatzglou, et al.
European Journal of Trauma & Dissociation = Revue Europeenne Du Trauma Et De La Dissociation|April 15, 2024
Psychological impact of the outbreak of COVID-19 on Holocaust survivors in FranceSamuel Sarfati, Andrée Katz, Marc Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2025
Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163Nabil F Saba, Yael Flamand, Derrick T Lin, et al.
Circulation|November 13, 2020
Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic DiseaseNicholas A Marston, Parth N Patel, Frederick K Kamanu, et al.
Pageof 41